Skip to main content
. 2021 Nov 8;23(2):94–100. doi: 10.1002/jgf2.506

TABLE 2.

Changes in prescription before and after transition to home care

Overall N Before transition 3 months after p value
Number of medications, mean ± SD 169 6.93 ± 3.73 6.72 ± 3.27 0.33*
MRCI‐J, mean ± SD (n = 160) 160 22.40 ± 11.96 21.09 ± 10.70 0.33*
Section A 4.45 ± 4.24 4.13 ± 2.61 0.27*
Section B 10.36 ± 6.05 9.74 ± 5.78 0.11*
Section C 7.59 ± 4.52 7.22 ± 4.25 0.18*
PIMs (STOPP‐J) 169 103 (60.9%) 94 (55.6%) 0.073**
Patients with polypharmacy
Number of medications, mean ± SD 129 8.18 ± 3.36 7.58 ± 3.06 0.024*
MRCI‐J, mean ± SD 123 26.20 ± 10.79 23.65 ± 10.37 0.004*
Section A 5.07 ± 4.47 4.35 ± 2.66 0.040*
Section B 12.24 ± 5.58 11.04 ± 5.76 0.011*
Section C 8.89 ± 4.28 8.26 ± 4.16 0.064*
PIMs (STOPP‐J), n (%) 129 87 (67.4) 80 (62.0) 0.17**
Patients with nonpolypharmacy
Number of medications, mean ± SD 40 2.88 ± 1.07 3.95 ± 2.21 0.001*
MRCI‐J, mean ± SD 37 9.77 ± 4.88 12.58 ± 6.64 0.008*
Section A 2.38 ± 2.43 3.38 ± 2.30 0.026*
Section B 4.12 ± 2.12 5.45 ± 3.22 0.010*
Section C 3.27 ± 1.74 3.76 ± 2.23 0.18*
PIMs (STOPP‐J), n (%) 40 16 (40.0) 14 (35.0) 0.63**

Section A: dosage forms, Section B: dosage frequency, Section C: additional instructions.

Abbreviations: MRCI‐J, medication regimen complexity index‐Japanese version; PIMs, potentially inappropriate medications; SD, standard deviation; STOPP‐J, Screening Tool for Older Persons' appropriate Prescriptions for Japanese.

*Paired t test, ** McNemar's test.